RubeOLA (Measles)-994

Test info

  
RubeOLA (Measles)
  
994
  
LAB994
  
MSO
  
Rubeola

Specimen

  
Throat swab (day 0-5 of rash)
Throat swab and urine (day 6-9 of rash)
  

Swab: Dacron (polyester) swab, BBL Culture swab, or Culturettes

Collection container: Copan UTM-RT transport (purple cap) with polyester sterile swab or Copan UTM-RT

   

Urine: Screw cap plastic container (sterile)

  

Lab Testing for Measles at the MDH Public Health Laboratory - MN Dept. of Health (state.mn.us)

Collect specimens for PCR as soon as possible after rash onset (maximum 9 days after rash onset).  Consider day 0 as rash onset date.

  • Collect a throat swab between 0 and 5 days of onset of rash
    • Vigorously swab tonsillar areas.
    • Use tongue blade to depress tongue to prevent contamination of swab with saliva.
  • Place swab into 2-3 ml of transport media.
  • Collect urine (in addition to the throat swab) between 6-9 days of onset of rash
    • Collect 10 - 40 mL of urine in a sterile urine specimen container.
    • Have patient void directly into container, collecting from the first part of the urine stream if possible.
    • First-morning voided specimens are ideal, but any urine collection is adequate.
  

Submit entire specimen

  
  
Throat swab and random urine
Nasopharyngeal (NP) swab
  

Nasopharyngeal (NP) swabs in UTM
(acceptable but not preferred)

  
  
  

Refrigerated (preferred)

Frozen - OK

  
  • Nasal swabs are not recommended and require prior approval from MDH
  • Dry swabs
  • Wood-tipped applicators, Cotton-tipped
    swabs, Calcium-alginate tipped swabs,
    Charcoal swabs, Gel swabs
  • Anaerobic media

Performance

  
MN Department of Health (MDH)
  
Mo - Fr
  
24 - 48 hours
  

Polymerase Chain Reaction (PCR)

Clinical and Interpretive info

  

Negative

MDH will contact the ordering provider directly with any positive results

  

Lab Testing for Measles at the MDH Public Health Laboratory

Consider lab testing for patients who meet the clinical case definition for measles:

  • Fever of 101°F (38.3°C) or higher and
  • Cough, coryza, or conjunctivitis and
  • A generalized, maculopapular rash lasting three days or more

Providers should ask about exposure, travel (past month), and MMR history. This helps us assess suspicion level, but providers should not rule-out a suspect diagnosis based on those factors. 

Billing

Tracking

  
03/25/2011
  
02/07/2024
  
02/07/2024